These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 26858444

  • 1. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL, Liu CD, You RI, Ching YH, Liang J, Ke L, Chen YL, Chen HC, Hsu HJ, Liou JW, Kieff E, Peng CW.
    Proc Natl Acad Sci U S A; 2016 Feb 23; 113(8):2229-34. PubMed ID: 26858444
    [Abstract] [Full Text] [Related]

  • 2. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD, Lee HL, Peng CW.
    J Virol; 2020 Mar 17; 94(7):. PubMed ID: 31941781
    [Abstract] [Full Text] [Related]

  • 3. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
    Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ, Shen CL, Chiu SJ, Kieff E, Peng CW.
    Proc Natl Acad Sci U S A; 2014 Jan 07; 111(1):243-8. PubMed ID: 24344309
    [Abstract] [Full Text] [Related]

  • 4. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A, Noguchi K, Minoshima M, Kashiwazaki G, Kanda T, Katayama K, Mitsuhashi J, Bando T, Sugiyama H, Sugimoto Y.
    Cancer Sci; 2011 Dec 07; 102(12):2221-30. PubMed ID: 21910783
    [Abstract] [Full Text] [Related]

  • 5. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA, Dheekollu J, Deakyne JS, Wiedmer A, Ramirez UD, Lieberman PM, Messick TE.
    J Virol; 2019 Oct 15; 93(20):. PubMed ID: 31142669
    [Abstract] [Full Text] [Related]

  • 6. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS, Malecka KA, Messick TE, Lieberman PM.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701406
    [Abstract] [Full Text] [Related]

  • 7. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J, Wiedmer A, Sentana-Lledo D, Cassel J, Messick T, Lieberman PM.
    J Virol; 2016 Jun 01; 90(11):5353-5367. PubMed ID: 27009953
    [Abstract] [Full Text] [Related]

  • 8. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance.
    Dheekollu J, Wiedmer A, Ayyanathan K, Deakyne JS, Messick TE, Lieberman PM.
    Cell; 2021 Feb 04; 184(3):643-654.e13. PubMed ID: 33482082
    [Abstract] [Full Text] [Related]

  • 9. Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1.
    Tempera I, Deng Z, Atanasiu C, Chen CJ, D'Erme M, Lieberman PM.
    J Virol; 2010 May 04; 84(10):4988-97. PubMed ID: 20219917
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM.
    Oncotarget; 2017 Jan 31; 8(5):7248-7264. PubMed ID: 28077791
    [Abstract] [Full Text] [Related]

  • 15. Replication licensing of the EBV oriP minichromosome.
    Hirai K, Shirakata M.
    Curr Top Microbiol Immunol; 2001 Jan 31; 258():13-33. PubMed ID: 11443858
    [Abstract] [Full Text] [Related]

  • 16. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
    Shen CL, Huang WH, Hsu HJ, Yang JH, Peng CW.
    Antiviral Res; 2019 Apr 31; 164():123-130. PubMed ID: 30817940
    [Abstract] [Full Text] [Related]

  • 17. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
    Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Tsurumi T.
    J Biol Chem; 2004 Dec 24; 279(52):54817-25. PubMed ID: 15498777
    [Abstract] [Full Text] [Related]

  • 18. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
    Lista MJ, Martins RP, Billant O, Contesse MA, Findakly S, Pochard P, Daskalogianni C, Beauvineau C, Guetta C, Jamin C, Teulade-Fichou MP, Fåhraeus R, Voisset C, Blondel M.
    Nat Commun; 2017 Jul 07; 8():16043. PubMed ID: 28685753
    [Abstract] [Full Text] [Related]

  • 19. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL, Maher M, Hayman JB, Ozer J, Zerby D, Yates JL, Lieberman PM.
    Virology; 1997 Dec 22; 239(2):340-51. PubMed ID: 9434725
    [Abstract] [Full Text] [Related]

  • 20. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK, Kim SY, Noh KW, Joo EH, Zhao B, Kieff E, Kang MS.
    Antiviral Res; 2014 Apr 22; 104():73-83. PubMed ID: 24486954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.